跳到主要內容區塊
Close
:::
Open
  1. Home_picHome
  2. > News

Events

:::
  • 20241002-1
  • Lectures
  • Institute of Biomedical Sciences
  • Location

    B1C Auditorium, IBMS

  • Speaker Name

    Dr. Yu Shyr (Vanderbilt Univ. Medical Center, Nashville, USA)

  • State

    Definitive

  • Url

Omics and AI: Redefining the Pathway to Cancer Biomarkers Research

2024-10-02 11:00 - 12:00

Add To Calendar

The key concepts of precision medicine are prevention and treatment strategies that take individual molecular profile and clinical information into account. Single-cell next-generation sequencing technologies (NGS), spatial transcriptomics, liquid biopsy for circulating tumor DNA (ctDNA) analysis, microbiomics, radiomics, and other types of high-throughput assays have exploded in popularity in recent years, thanks to their ability to produce an enormous volume of data quickly and at relatively low cost. The emergence of these big data has advanced the goals of precision medicine; however, across the entire continuum of big data capture and utilization, many more challenges lie ahead—from analysis of high-throughput biomarkers to maximum exploitation of the electronic health record (EHR), to the ultimate goal of clinical guidance based on a patient’s genome.
In this presentation, I will offer some perspectives on the changing landscape for applied mathematical and statistical data science, including the concept of merging different Omics data; the need for biologists and clinicians to adjust their mindset around the explosive growth in information technology; machine learning; and the AI revolution. These areas present great opportunities for our profession to strengthen our role in the precision medicine research arena. I will finish up with my recent research about single cell RNA-seq data analysis which we developed a new method to identify dysregulated ligand-receptor interactions from single cell transcriptomics.

回頂端